maintenance dose of tirzepatide for weight loss After Mounjaro (Tirzepatide) Weight Loss Injections

If serious gastrointestinal symptoms occur, the dose may be delayed or reverted to the previous dose until symptoms resolve

Carry Your Prescription Information Always have a copy of your prescription or a doctors note explaining your semaglutide use

Mounjaro (active ingredient: tirzepatide) subcutaneous injection Initial FDA Approval: 2022 Side Effect Update Date: May 28, 2025 Medication Description: Treats type 2 diabetes Updated Side Effects/Safety Information: A new warning about the risk of serious kidney injury caused by dehydration due to gastrointestinal adverse effects like diarrhea and vomiting

K-means clustering algorithms: A comprehensive review, variants analysis, and advances in the era of big data